{
  "retracted": false,
  "timestamp": 1399334400000,
  "updates": [
    {
      "timestamp": 1581716440236,
      "identifier": {
        "doi": "10.1038/ajg.2014.69"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/ajg.2013.354"
  },
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Erratum: EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn ºs Disease Activity: Role of Cross-Sectional Imaging"
}
